Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | — |
The patient did not take all four doses of Vivotif; Case reference number US-BN-2025-001421 is a spontaneous case initially received from a nurse via Communication (reference number: USBAV25-2056) on 18-Aug-2025 and concerns a patient of unspecified age and gender. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient took Vivotif (batch number: unknown) at an unknown dose, route, or site of administration for an unknown indication, and did not take all four doses (explicitly coded as 'incomplete course of vaccination'). At the time of the initial report, it was unknown if the patient experienced any adverse events due to Vivotif. *As reported, it was confirmed that the reporter was unable to provide the requested information as inquiry was not regarding a specific patient but was addressing common questions asked regarding missed doses*. Additional information received from a nurse via Bavarian Nordic on 18-Aug-2025. New information included: Conformation that the inquiry is not a hypothetical question that is an actual case. All follow-up information is blended into the case narrative above, with the latest information presented between asterisks (*). Follow up information received from a nurse via Communication on 25-Sep-2025: New information included confirmation about the reporter unable to provide the details.; Reporter's Comments: A patient of unspecified age and gender took Vivotif for an unknown indication, and did not take all four doses, which is considered as incomplete course of vaccination. It was unknown if the patient experienced any adverse events due to Vivotif. Incomplete course of vaccination is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unspecified age and gender took Vivotif for an unknown indication, and did not take all four doses, which is considered as incomplete course of vaccination. It was unknown if the patient experienced any adverse events due to Vivotif. Incomplete course of vaccination is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE